A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical efficacy and safety in patients with Acute Bronchitis or Secondary
Infection of Chronic Respiratory Diseases receiving a dose of 2 g of azithromycin in the SR
formulation.